Robert Klupacs, Director at Bio-Gene Technology Ltd., holds 3.96M shares in Bio-Gene Technology Ltd. (Ticker: AU:BGT), holds 390.98K shares in Opthea Limited (Ticker: CKDXF). Most recently, Robert Klupacs Bought ― shares of Bio-Gene Technology Ltd. on Jun 16, 2022 for an estimated value of 3.61K.